<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7215134\results\search\testTrace\results.xml">
  <result pre="repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2" exact="treatment" post="http://orcid.org/0000-0002-6380-7114BuonaguroLuigil.buonaguro@istitutotumori.na.it1BuonaguroFranco M.2[1], grid.417893.00000 0001 0807 2568Laboratory of Innovative Immunological"/>
  <result pre="repositioning of the anti-HCV direct antiviral agent (DAA) Sofosbuvir as" exact="treatment" post="for SARS-CoV-2. Indeed, the RNA-dependent RNA-polymerases (RdRp) of the"/>
  <result pre="weak evidences from retrospective analyses suggesting clinical benefit in the" exact="treatment" post="of the two previous coronavirus epidemics [6]. Similarly, anti-malaria"/>
  <result pre="50 percent of patients in 10 days in the 5-day" exact="treatment" post="group and 11 days in the 10-day treatment group"/>
  <result pre="the 5-day treatment group and 11 days in the 10-day" exact="treatment" post="group (https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19). However, a trial conducted in China showed"/>
  <result pre="of the HCV NS5B RdRp protein, as antiviral in the" exact="treatment" post="of the SARS-CoV-2 infection has an extremely high potentiality"/>
  <result pre="RdRp protein, as antiviral in the treatment of the SARS-CoV-2" exact="infection" post="has an extremely high potentiality of success, as recently"/>
  <result pre="[17], and is suggested as a potential drug for the" exact="treatment" post="of COVID-19 in the very recent EASL-ESCMID position paper"/>
  <result pre="long-lasting use in patients for treating and eradicating HCV chronic" exact="infection" post="provides also the full knowledge of its safety profile"/>
  <result pre="YC, Chan KH, Wu TC, Chan JMC, et al. Consistent" exact="detection" post="of 2019 novel coronavirus in saliva. Clin Infect Dis."/>
  <result pre="2020;ciaa149. 10.1093/cid/ciaa149. Online ahead of print. 5.RotheCSchunkMSothmannPBretzelGFroeschlGWallrauchCet al.Transmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in GermanyN Engl J Med202038297097110.1056/NEJMc200146832003551"/>
  <result pre="GermanyN Engl J Med202038297097110.1056/NEJMc200146832003551 6.ChuCMChengVCHungIFWongMMChanKHChanKSet al.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findingsThorax20045925225610.1136/thorax.2003.01265814985565 7.Cortegiani A,"/>
  <result pre="review on the efficacy and safety of chloroquine for the" exact="treatment" post="of COVID-19. J Crit Care. 2020;S0883-9441(20)30390â€&quot;7. 10.1016/j.jcrc.2020.03.005. Online ahead"/>
 </snippets>
</snippetsTree>
